1. Home
  2. ADPT vs XRAY Comparison

ADPT vs XRAY Comparison

Compare ADPT & XRAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$18.46

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

HOLD

Current Price

$12.70

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADPT
XRAY
Founded
2009
1899
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2019
1987

Fundamental Metrics

Financial Performance
Metric
ADPT
XRAY
Price
$18.46
$12.70
Analyst Decision
Strong Buy
Hold
Analyst Count
10
12
Target Price
$16.60
$14.50
AVG Volume (30 Days)
1.9M
4.0M
Earning Date
02-05-2026
02-26-2026
Dividend Yield
N/A
5.03%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$252,754,000.00
$3,624,000,000.00
Revenue This Year
$50.86
N/A
Revenue Next Year
$0.53
$0.86
P/E Ratio
N/A
N/A
Revenue Growth
42.57
N/A
52 Week Low
$6.26
$9.85
52 Week High
$20.76
$20.60

Technical Indicators

Market Signals
Indicator
ADPT
XRAY
Relative Strength Index (RSI) 59.49 59.24
Support Level $16.55 $11.95
Resistance Level $19.16 $12.60
Average True Range (ATR) 1.00 0.53
MACD 0.18 0.06
Stochastic Oscillator 82.08 81.66

Price Performance

Historical Comparison
ADPT
XRAY

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

Share on Social Networks: